User profiles for Dwomoa Adu
Dwomoa AduSchool of Medicine and Dentistry, University of Ghana Verified email at ug.edu.gh Cited by 16313 |
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
…, KR Tuttle, DC Wheeler, KU Eckardt, D Adu… - The Lancet, 2017 - thelancet.com
The global nephrology community recognises the need for a cohesive plan to address the
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …
A renal registry for Africa: first steps
…, J Plange-Rhule, CR Swanepoel, D Adu… - Clinical kidney …, 2016 - academic.oup.com
There is a dearth of data on end-stage renal disease (ESRD) in Africa. Several national
renal registries have been established but have not been sustainable because of resource …
renal registries have been established but have not been sustainable because of resource …
[HTML][HTML] Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
HIV-positive individuals are at increased risk for kidney disease, including HIV-associated
nephropathy, noncollapsing focal segmental glomerulosclerosis, immune-complex kidney …
nephropathy, noncollapsing focal segmental glomerulosclerosis, immune-complex kidney …
Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials
Objective: To study the effect of interleukin-2 receptor monoclonal antibodies on acute rejection
episodes, graft loss, deaths, and rate of infection and malignancy in patients with renal …
episodes, graft loss, deaths, and rate of infection and malignancy in patients with renal …
The value of pulse cyclophosphamide in ANCA‐associated vasculitis: meta‐analysis and critical review
K Groot, D Adu, COS Savage - Nephrology Dialysis …, 2001 - academic.oup.com
Background. The study aimed at studying efficacy and adverse effects of pulse cyclophosphamide
(pCyc) treatment and to compare it to continuous cyclophosphamide (cCyc) for …
(pCyc) treatment and to compare it to continuous cyclophosphamide (cCyc) for …
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis
…, P Sampson, L Foggensteiner, D Adu… - Clinical Journal of the …, 2009 - journals.lww.com
Background and objectives: Extended hemodialysis using a high cut-off dialyzer (HCO-HD)
removes large quantities of free light chains in patients with multiple myeloma. However, the …
removes large quantities of free light chains in patients with multiple myeloma. However, the …
Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake
Copy number (CN) variation (CNV) has been shown to be common in regions of the genome
coding for immune-related genes, and thus impacts upon polygenic autoimmunity. Low CN …
coding for immune-related genes, and thus impacts upon polygenic autoimmunity. Low CN …
[HTML][HTML] The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease
Glomerular-derived proteins may activate tubular cells to express the macrophage-directed
chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2). Macrophages at interstitial …
chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2). Macrophages at interstitial …
[HTML][HTML] Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial
…, TL Chapman, MM Langdon, C Ferguson, D Adu… - The Lancet, 2013 - thelancet.com
Background Membranous nephropathy leads to end-stage renal disease in more than 20%
of patients. Although immunosuppressive therapy benefits some patients, trial evidence for …
of patients. Although immunosuppressive therapy benefits some patients, trial evidence for …
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group
In 2008, the World Health Assembly endorsed WHO’s Global Action Plan for the Prevention
and Control of Non-Communicable Diseases (NCDs) 2013–2020, 1 based on the realisation …
and Control of Non-Communicable Diseases (NCDs) 2013–2020, 1 based on the realisation …